Maryland Pharmacist Contraception Services Training Program
Course Details
Target Audience
Pharmacists
Registration and Course Fee
- Pharmacists $150
- Pharmacy students/others $100
Type of CPE Activity
Application
Educational Methods
Lecture presentation with interactive questions and clinical case applications.
This home study training program is approved by the Maryland Board of Pharmacy as required training for pharmacists to prescribe hormonal contraception (pills, patch, ring, injection, emergency contraception) per statewide protocol. This program includes background, review of methods, protocol procedures, patient education, service implementation, resources for both pharmacists and patients, and payment for pharmacist services.
Pharmacists can earn up to 3 contact hours (0.3 CEUs) of ACPE-accredited continuing pharmacy education (CPE) credit.
Learning Objectives
Upon completing this course, the participant will be able to:
Pharmacists
- Discuss the impact of barriers to contraceptive use.
- Describe pharmacist procedures for contraception services, including state-specific requirements for prescribing and dispensing.
- Identify appropriate screening assessments for the various methods of contraception.
- Apply the medical eligibility criteria for contraceptive use to individual patients.
- Provide accurate patient counseling about the mechanism, effectiveness, benefits, risks, and instructions for use for contraception methods.
- Assist patients in selecting method(s) of contraception.
- Manage side effects and refer for further evaluation when appropriate.
- Implement contraception prescribing in a pharmacy practice setting.
Faculty Member(s)
Sally Rafie, PharmD, BCPS, APh, NCMP, FCCP
- Pharmacist Specialist, UC San Diego Health
- Assistant Clinical Professor, UCSD Skaggs School of Pharmacy & Pharmaceutical Sciences (w/s)
- Founder and Advanced Practice Pharmacist, The Pharmacists Clinic
- Founder, Birth Control Pharmacist
Planning Committee and Contributors
Sharon K. Park, PharmD, MEd, BCPS
Associate Professor, Clinical & Administrative Sciences, School of Pharmacy, Notre Dame of Maryland University
Nishant Shah, MD
Physician, Planned Parenthood of Maryland
Denise Fu, PharmD, BCACP
Clinical Programs Manager of Patient Care Services, Johns Hopkins Home Care Group
Anne E. Burke, MD, MPH
Obstetrician-Gynecologist, Director of Family Planning and Associate Professor, Johns Hopkins University
Danya M. Qato, PhD, PharmD, MPH
Assistant Professor of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy
Faculty and Program Planning Committee Disclosures
Sally Rafie, PharmD serves as a Clinical Advisory Board Member for Afaxys, Inc and Speaker for Therapeutics MD. All other individuals involved in the development of this material declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria.
Course Completion and Credit
After registration for this activity, you will receive an email with the course login. Retain this email for access to the course and credit completion.
Join our email list to be notified of other live and home study programs.
Note: Registration fees are non-refundable.
To schedule a live web-based training session, contact us.
If you are a pharmacist in another state, contact us for the appropriate course accepted by your state board of pharmacy.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Pharmacy Education (ACPE) through the joint providership of University Learning Systems and Birth Control Pharmacist. University Learning Systems is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Numbers are: 0741-9999-23-032-H01-P. This program provides 3.0 contact hours (0.3 CEUs) of continuing education credit for pharmacists. No fractional hours of credit will be given.